This inventor holds 1 USPTO granted patent. Top assignee: Nanyang Technological University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Maciej Bartosz Holowko: Innovator in Pathogen Detection
Introduction
Maciej Bartosz Holowko is a notable inventor based in Singapore, recognized for his contributions to the field of biotechnology. His innovative work focuses on developing systems that enhance the detection and response to pathogenic microorganisms.
Latest Patents
Holowko holds a patent for a "Recombinant expression system that senses pathogenic microorganisms." This invention comprises a sophisticated recombinant expression system that includes a first nucleotide sequence encoding a protein from a quorum sensing system. This system is capable of detecting the presence and amount of a microorganism of interest by forming a complex with a marker molecule. Additionally, it features a second nucleotide sequence that encodes an antimicrobial peptide effective against the detected microorganism. The system also includes a third nucleotide sequence that encodes a genetic inverter, which regulates the expression of the antimicrobial peptide based on the concentration of the detected microorganism. This innovative approach has significant implications for pathogen detection and response.
Career Highlights
Holowko is affiliated with Nanyang Technological University, where he continues to advance his research and development efforts. His work is characterized by a commitment to addressing critical challenges in microbial detection and treatment.
Collaborations
He collaborates with esteemed colleagues, including Chueh Loo Poh and Premkumar Jayaraman, to further enhance the impact of his research.
Conclusion
Maciej Bartosz Holowko's innovative contributions to pathogen detection through his patented recombinant expression system exemplify the potential of biotechnology in addressing public health challenges. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
